tiprankstipranks

Donald W DeGolyer Insider Profile

4 Followers
Donald W DeGolyer, Chief Operating Officer,Pharma at Endo International, holds 5.74K shares in Endo International (Ticker: ENDPQ), holds ― shares in Tyme Technologies (Ticker: TYME), holds 111.10K shares in Emergent Biosolutions (Ticker: EBS).
tipranks
Donald W DeGolyer

Donald W DeGolyer
Endo International (ENDPQ)
Chief Operating Officer,Pharma

Not Ranked
Donald W DeGolyer has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$1M
100.00%
A breakdown of Donald W DeGolyer's holdings

Insider Roles

Emergent Biosolutions
(EBS)
Director
Roles that Donald W DeGolyer holds in companies

Most Profitable Insider Trade

Stock:
Emergent Biosolutions
(EBS)
Rating:Informative Sell
Date:Nov 14, 2024 - Today
Return:-2.20%
The most profitable trade made by Donald W DeGolyer

Donald W DeGolyer's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
ENDPQ
Endo International
Aug 05, 2014
Uninformative Sell
303.66K
$68.92
TYME
Tyme Technologies
Emergent Biosolutions
Nov 14, 2024
Director
Informative Sell
272.75K
$1.09M
List of latest transactions for each holding click on a transaction to see Donald W DeGolyer's performance on stock

Donald W DeGolyer insider profile FAQ

What is the percentage of profitable transactions made by Donald W DeGolyer?
The percentage of profitable transactions made by Donald W DeGolyer is ―.
    What is the average return per transaction made by Donald W DeGolyer?
    The average return per transaction made by Donald W DeGolyer is ―.
      What stocks does Donald W DeGolyer hold?
      Donald W DeGolyer holds: ENDPQ, TYME, EBS stocks.
        What was Donald W DeGolyer’s latest transaction?
        Donald W DeGolyer latest transaction was an Uninformative Sell of $303.66K.
          What was Donald W DeGolyer's most profitable transaction?
          Donald W DeGolyer’s most profitable transaction was an Informative Sell of EBS stock on November 14, 2024. The return on the trade was -2.20%.
            What is Donald W DeGolyer's role in Endo International?
            Donald W DeGolyer's role in Endo International is Chief Operating Officer,Pharma.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.